US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VictoryShares Pioneer Asset-Based Income ETF

24.48

-0.0454-0.19%

Post-market: 24.480.00000.00%19:30 EDT

Volume:36.02K

Turnover:881.26K

Market Cap:525.02M

PE:- -

High:24.49

Open:24.47

Low:24.45

Close:24.52

52wk High:25.10

52wk Low:24.45

Shares:21.45M

Float Shares:21.45M

Volume Ratio:0.40

T/O Rate:0.17%

Dividend:1.57

Dividend Rate:6.41%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Assembly Biosciences Plans to Present Posters Featuring New Phase 1a Data From ABI-6250 Program

MT Newswires Live

Octopus APAC Details Profitability Drive and ABI Termination Response

Aegon warns red tape is blocking pension investment spree

MapLight Announces Topline Results from Phase 2 IRIS Study for ML-004 in Autism Spectrum Disorder

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/ABI"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ABI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABI\",,,,,undefined,":{"symbol":"ABI","market":"US","secType":"STK","nameCN":"VictoryShares Pioneer Asset-Based Income ETF","latestPrice":24.475,"timestamp":1791576000000,"preClose":24.5204,"halted":0,"volume":36017,"hourTrading":{"tag":"盘后","latestPrice":24.475,"preClose":24.475,"latestTime":"19:30 EDT","volume":1,"amount":24.47,"timestamp":1791588604863,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0018515195510675692,"floatShares":21451303,"shares":21451303,"eps":0,"marketStatus":"Market Closed","change":-0.0454,"latestTime":"10-09 16:00:00 EDT","open":24.465,"high":24.485,"low":24.45,"amount":881255.4559879999,"amplitude":0.001427,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":24.5204,"sharesOutstanding":2275000,"nav":24.446848,"aum":528662050,"dividendRate":0.064118,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":24.475,"preClose":24.475,"latestTime":"19:30 EDT","volume":1,"amount":24.47,"timestamp":1791588604863,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.39552173192481377},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABI\",,,,,undefined,":{"symbol":"ABI","floatShares":21451303,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.39552173192481377,"shares":21451303,"dividePrice":1.5693,"high":24.485,"amplitude":0.001427,"preClose":24.5204,"low":24.45,"week52Low":24.45,"pbRate":"--","week52High":25.1,"institutionHeld":0,"latestPrice":24.475,"eps":0,"divideRate":0.064118,"volume":36017,"delay":0,"ttmEps":0,"open":24.465,"prevYearClose":24.835,"prevWeekClose":24.505,"prevMonthClose":24.5379,"prevQuarterClose":24.5379,"fiveDayClose":24.505,"twentyDayClose":24.555,"sixtyDayClose":24.78},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ABI\",params:#limit:5,,,undefined,":[{"date":"2026-10-08","symbol":"ABI","amount":0.069025,"announcedDate":"2026-10-07","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-10-08","defaultRemindTime":1791466200000,"name":"VictoryShares Pioneer Asset-Based Income ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-09","payableDate":"2026-10-08","currency":"USD","dateTimestamp":1791432000000,"payDate":"2026-10-09"},{"date":"2026-09-09","symbol":"ABI","amount":0.125537,"announcedDate":"2026-09-08","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-09","defaultRemindTime":1788960600000,"name":"VictoryShares Pioneer Asset-Based Income ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-10","payableDate":"2026-09-09","currency":"USD","dateTimestamp":1788926400000,"payDate":"2026-09-10"},{"date":"2026-08-07","symbol":"ABI","amount":0.122444,"announcedDate":"2026-08-06","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-07","defaultRemindTime":1786109400000,"name":"VictoryShares Pioneer Asset-Based Income ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-10","payableDate":"2026-08-07","currency":"USD","dateTimestamp":1786075200000,"payDate":"2026-08-10"},{"date":"2026-07-09","symbol":"ABI","amount":0.138686,"announcedDate":"2026-07-08","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-09","defaultRemindTime":1783603800000,"name":"VictoryShares Pioneer Asset-Based Income ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-10","payableDate":"2026-07-09","currency":"USD","dateTimestamp":1783569600000,"payDate":"2026-07-10"},{"date":"2026-06-09","symbol":"ABI","amount":0.123144,"announcedDate":"2026-06-08","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-09","defaultRemindTime":1781011800000,"name":"VictoryShares Pioneer Asset-Based Income ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-10","payableDate":"2026-06-09","currency":"USD","dateTimestamp":1780977600000,"payDate":"2026-06-10"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ABI\",market:\"US\",,,undefined,":[{"executeDate":"2025-07-10","recordDate":"2025-07-10","paymentDate":"2025-07-11","value":0.01517,"currency":"USD"},{"executeDate":"2025-08-06","recordDate":"2025-08-06","paymentDate":"2025-08-07","value":0.083425,"currency":"USD"},{"executeDate":"2025-09-08","recordDate":"2025-09-08","paymentDate":"2025-09-09","value":0.132826,"currency":"USD"},{"executeDate":"2025-10-09","recordDate":"2025-10-09","paymentDate":"2025-10-10","value":0.146893,"currency":"USD"},{"executeDate":"2025-11-07","recordDate":"2025-11-07","paymentDate":"2025-11-10","value":0.122586,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ABI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ABI\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673608693","title":"Assembly Biosciences Plans to Present Posters Featuring New Phase 1a Data From ABI-6250 Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2673608693","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673608693?lang=en_us&edition=fundamental","pubTime":"2026-10-06 00:48","pubTimestamp":1791218937,"startTime":"0","endTime":"0","summary":"Assembly Biosciences  said phase 1a study of ABI-6250 demonstrated potent target engagement and further supported the therapy's safety profile. The company plans to present the findings at the annual meeting of the American Association for the Study of Liver Diseases in November.The company said Monday that the phase 1a findings support its plans to begin phase 2 studies in patients with chronic hepatitis delta virus infection in Q4 of 2026 and in patients with cholestatic liver diseases in Q1 of 2027.ABI-6250 demonstrated dose-dependent, reversible increases in total and conjugated bile acids consistent with sodium taurocholate co-transporting polypeptide target engagement in the randomized, blinded phase 1a study, the company said.Additionally, ABI-6250 was well tolerated at the doses evaluated, with no serious adverse events reported, according to a statement.Price: 22.88, Change: +0.34, Percent Change: +1.51","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ABI","ASMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662520874","title":"Octopus APAC Details Profitability Drive and ABI Termination Response","url":"https://stock-news.laohu8.com/highlight/detail?id=2662520874","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662520874?lang=en_us&edition=fundamental","pubTime":"2026-08-25 01:32","pubTimestamp":1787592755,"startTime":"0","endTime":"0","summary":"GS Holdings Ltd. (Singapore) ( ($SG:43A) ) has provided an announcement. Octopus (APAC) Holdings laid out key priorities to turning its loss-making...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/octopus-apac-details-profitability-drive-and-abi-termination-response?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/octopus-apac-details-profitability-drive-and-abi-termination-response?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BSNM7G36.USD","LU0942090050.USD","BK4550","IE00B19Z3B42.SGD","LU1868837300.USD","LU2471134523.USD","LU2237443382.USD","LU0251131958.USD","BK4588","LU1791807156.HKD","LU0742534661.SGD","LU1868836757.USD","BK4533","LU0096364046.USD","IE0004091025.USD","ABI","LU0251142724.SGD","STmain","LU2750360641.GBP","BK4209","LU0210536198.USD","IE00BFXG1179.USD","LU2896262040.SGD","BK4504","LU1868836914.USD","LU0061475181.USD","LU0868494708.USD","LU1868836591.USD","LU2237443549.SGD","LU2471134879.HKD","LU2471134952.CNY","LU1804176565.USD","IE0034235188.USD","LU1894683264.USD","LU2750360997.AUD","LU2237443895.HKD","SG","LU0048573561.USD","LU2237443465.HKD","APAC","BK4127","GSX","LU2237438978.USD","LU0868494617.USD","LU1894683348.USD","LU1668664300.SGD","LU2237443978.SGD","LU1144417596.USD","LU2237443622.USD","BK4552"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651415534","title":"Aegon warns red tape is blocking pension investment spree","url":"https://stock-news.laohu8.com/highlight/detail?id=2651415534","media":"cityam","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651415534?lang=en_us&edition=fundamental","pubTime":"2026-07-16 13:00","pubTimestamp":1784178000,"startTime":"0","endTime":"0","summary":"One Mansion House signatory has raised concerns over regulatory barriers  Aegon has warned that regulation is holding back some of Britain’s top pension fund managers from pumping cash into the country’s start-ups and unlisted companies.The pension giant, which manages 160bn of assets in the UK alone, was one of 11 companies alongside Aviva and Legal & General to commit to investing five per cent of their assets in unlisted equities by 2030. However, Aegon has warned that regulatory hurdles could throw timelines into doubt as the City marks the three year anniversary of the agreement’s signing.“While we have made meaningful progress, we remain concerned about the timeline to the 2030 Mansion House Compact target,” Lorna Blyth, managing director, investment proposition at Aegon, told City AM.Providers said “managing appropriate fee structures remains problematic”, as certain models used in private capital markets are “financially unfeasible”.To protect savers from having their pension p","market":"fut","thumbnail":"https://www.cityam.com/wp-content/uploads/2026/02/London-insurance-e1770395080662.jpg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2026/02/London-insurance-e1770395080662.jpg?w=824&h=463&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/aegon-warns-red-tape-is-blocking-pension-investment-spree/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/aegon-warns-red-tape-is-blocking-pension-investment-spree/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["ITDE","ABI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645489021","title":"MapLight Announces Topline Results from Phase 2 IRIS Study for ML-004 in Autism Spectrum Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2645489021","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645489021?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:00","pubTimestamp":1782126000,"startTime":"0","endTime":"0","summary":"The IRIS Phase 2 trial did not meet its primary endpoint in social communication deficits associated with ASD A prespecified analysis in adolescents with moderate to severe baseline irritability (ABC-","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/22/3315170/0/en/MapLight-Announces-Topline-Results-from-Phase-2-IRIS-Study-for-ML-004-in-Autism-Spectrum-Disorder.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065732104.USD","BK4018","ABI","SPB","ASD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ABI\",params:#limit:6,delay:false,,,undefined,":[]}}